In a study, calcein and doxorubicin‐loaded liposomes were functionalized with the monoclonal antibody trastuzumab for targeting human epidermal growth factor receptor 2 (HER2) positive breast cancer cells. Here, ERBB2 is linked to breast carcinoma.